Accéder directement au contenu Accéder directement à la navigation
Nouvelle interface
Article dans une revue

LPCAT3 deficiency in hematopoietic cells alters cholesterol and phospholipid homeostasis and promotes atherosclerosis

Thomas Charles 1, 2, 3 Antoine Jalil 1, 2, 3 Charlène Magnani 1, 2, 3 Minako Ishibashi 1, 2, 3 Ronan Quéré 1, 2, 3 Thibaut Bourgeois 1, 2, 3 Victoria Bergas 4 Louise Ménégaut 1, 2, 3 Danish Patoli 1, 2, 3 Naïg Le Guern 1, 2, 3 Jérôme Labbé 1, 2, 3 Thomas Gautier 1, 2, 3 Jean-Paul Pais de Barros 1, 2, 3, 4 Laurent Lagrost 1, 2, 3, 5 David Masson 1, 2, 3, 5, * 
Abstract : Background and aims LPCAT3 plays a major role in phospholipid metabolism in the liver and intestine. However, the impact of LPCAT3 on hematopoietic cell and macrophage functions has yet to be described. Our aim was to understand the functions of LPCAT3 in macrophages and to investigate whether LPCAT3 deficiency in hematopoietic cells may affect atherosclerosis development. Methods Mice with constitutive Lpcat3 deficiency (Lpcat3−/−) were generated. We used fetal hematopoietic liver cells to generate WT and Lpcat3−/− macrophages in vitro and to perform hematopoietic cell transplantation in recipient Ldlr−/− mice. Results Lpcat3-deficient macrophages displayed major reductions in the arachidonate content of phosphatidylcholines, phosphatidylethanolamines and, unexpectedly, plasmalogens. These changes were associated with altered cholesterol homeostasis, including an increase in the ratio of free to esterified cholesterol and a reduction in cholesterol efflux in Lpcat3−/− macrophages. This correlated with the inhibition of some LXR-regulated pathways, related to altered cellular availability of the arachidonic acid. Indeed, LPCAT3 deficiency was associated with decreased Abca1, Abcg1 and ApoE mRNA levels in fetal liver cells derived macrophages. In vivo, these changes translated into a significant increase in atherosclerotic lesions in Ldlr−/− mice with hematopoietic LPCAT3 deficiency. Conclusions This study identifies LPCAT3 as a key factor in the control of phospholipid homeostasis and arachidonate availability in myeloid cells and underlines a new role for LPCAT3 in plasmalogen metabolism. Moreover, our work strengthens the link between phospholipid and sterol metabolism in hematopoietic cells, with significant consequences on nuclear receptor-regulated pathways and atherosclerosis development.
Liste complète des métadonnées
Contributeur : LNC - université de Bourgogne Connectez-vous pour contacter le contributeur
Soumis le : lundi 25 juin 2018 - 09:51:00
Dernière modification le : lundi 28 novembre 2022 - 10:38:07



Thomas Charles, Antoine Jalil, Charlène Magnani, Minako Ishibashi, Ronan Quéré, et al.. LPCAT3 deficiency in hematopoietic cells alters cholesterol and phospholipid homeostasis and promotes atherosclerosis. Atherosclerosis, 2018, 275, pp.409-418. ⟨10.1016/j.atherosclerosis.2018.05.023⟩. ⟨hal-01822414⟩



Consultations de la notice